Evidence map›Paper›PMID 12717428›Full record

ArticleOncogene2003

Induction of hepatocyte proliferation and death by modulation of T-Antigen expression.

Sarah A Comerford, David E Clouthier, Elizabeth A Hinnant, Robert E Hammer

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Sarah A ComerfordDepartment of Biochemistry and Cecil and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center at Dallas, 75390-9050, USA.
David E Clouthier
Elizabeth A Hinnant
Robert E Hammer
Institut de Médecine de la Reproduction · FRThe University of Texas Southwestern Medical Center · US

Funding

TGF-BETA SIGNALING IN LIVER HOMEOSTASISR01DK053789 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI HAMMER, ROBERT E · 1998 to 2000
$114k
NIDDK NIH HHS DK 53789
6 · The paper itself

Abstract

Mice expressing SV40 T-Antigen in liver under control of the phosphoenolpyruvate carboxykinase promoter were generated. By altering the carbohydrate content of the diet, TAg expression, the rate of hepatocyte proliferation and apoptosis, and hence hepatocarcinogenesis, could be regulated. Carbohydrate-mediated suppression of TAg resulted in slow hepatic growth that progressed to focal hepatocellular carcinoma (HCC) after a long latency period. In contrast, induction of TAg by feeding mice a low carbohydrate diet resulted in massive hepatomegaly that progressed rapidly to diffuse multifocal HCC. Hepatic TAg expression could be efficiently repressed by switching mice from the low to the high-carbohydrate diet, which if instigated prior to the development of HCC, resulted in rapid regression through a p53-independent reduction in hepatocyte proliferation and an increase in hepatocyte apoptosis. Although liver growth was accompanied by compensatory hepatocyte apoptosis, an apoptotic deficit developed following chronic exposure to high levels of TAg. This was associated with Akt phosphorylation and increased expression of the antiapoptotic molecules bfl-1/A1, TIAP, and A20. Mice were resistant to Fas-induced hepatocellular apoptosis due to severely impaired caspase activation and failed activation of the mitochondrial amplification loop. This model will be useful to investigate oncogene-mediated disruption of the cell cycle and apoptosis, and to determine which processes constitute fixed, or reversible aspects of the tumorigenic process.

Indexed as

Protein Serine-Threonine KinasesAnimalsAntigens, Viral, TumorApoptosisBH3 Interacting Domain Death Agonist ProteinCarcinoma, HepatocellularCarrier ProteinsCaspasesCell DivisionGene Expression Regulation, NeoplasticHepatocytesMicePhosphorylationProto-Oncogene ProteinsProto-Oncogene Proteins c-aktTumor Suppressor Protein p53Antigens, Viral, TumorBH3 Interacting Domain Death Agonist ProteinBid protein, mouseCarrier ProteinsCaspasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktTumor Suppressor Protein p53

Identifiers

PMID12717428
OpenAlexW2004730096

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.